KTN's online platform helps you to make the connections you need


The Knowledge Transfer Network (KTN) has refreshed its online platform to intelligently connect you to relevant events, funding, thought pieces and specialist staff to help your business innovate and grow.

You can discover content using your area of interest, from Defence Security to transport; from space to health – all major UK economic sectors are covered. Once you have selected your interests, using our intelligent tagging system, we will then display rich and relevant content related to your area, often from surprising sources.

An example might be new satellite technology from the space sector that is applicable in the agri-food sector. KTN-UK.co.uk will help you form these unusual and valuable connections.

All content on the platform has been carefully curated by our team of innovation specialists – not by an automated algorithm – so you can be confident that KTN is connecting you to the most relevant cutting-edge information.


The move also marks a closer alignment with our main funder, Innovate UK , with the website branding making a clear visual link. Knowledge Transfer Network is Innovate UK's innovation network partner, and also works with other funders to provide innovation networking services and fulfil our mission to drive UK growth.

We link new ideas and opportunities with expertise, markets and finance through our network of businesses, universities, funders and investors. From agri-food to autonomous systems and from energy to design, KTN combines expertise in all sectors with the ability to cross boundaries. Connecting with KTN can lead to potential partners, horizon-expanding events and innovation insights relevant to your needs.

Visit our people pages to connect directly with expertise in your sector.

Visit the KTN refreshed online platfom here

« go back

UK companies advance development of regenerative medicines and cell therapies

With the 2015 competition ‘Developing Regenerative Medicines and Cell Therapies’, Innovate UK will invest up to £8 million in collaborative R&D projects that address critical challenges faced by UK companies developing regenerative medicines and cell therapies as clinical treatments and commercial products.

The competition aimed to advance the commercial development of new treatments and underpinning technologies by supporting a number of projects that connect the research pathway, from early discovery to clinical application and commercial supply.

The five projects detailed below have succeeded in the final assessment of the competition, and their grant award confirmation is subject to the offer conditions being met.

  1. Next generation DNA constructs for the rapid and safe manufacture of AAV vectors for Regenerative Gene Therapy

Lead name: Cobra Biologics Ltd

Partner names: Touchlight Genetics Ltd

  1. Development of an Industrial Manufacturing Platform for Adeno-Associated Virus (AAV) production to support Regenerative Gene Therapy products

Lead name: Cobra Biologics Ltd

Partner names: Centre for Process Innovation Limited

  1. Enhanced Vector Bioprocessing Technologies for Cell and Gene Therapies

Lead name: Synpromics Ltd

Partner names: Cell Therapy Catapult

  1. Stem cell-derived exosomes for regenerative medicine

Lead name: ReNeuron Limited

Partner names: University College LondonCell Therapy Catapult

  1. CAR Therapy for T Cell Malignancies

Lead name: Autolus Ltd

Partner names: University College London

Find out more about the competition and the selected projects here